Asian Stocks Up, Boosted by Yellen Push for U.S. Stimulus Measures

Investing.com

Published Feb 07, 2021 10:08PM ET

By Gina Lee

Investing.com – Asia Pacific stocks were up on Monday morning, starting the week with on an optimistic note after U.S. Secretary of the Treasury Janet Yellen pushed for a U.S. stimulus package to be passed and COVID-19 trends showed improvements.

Japan’s Nikkei 225 jumped 2.15% by 10:06 PM ET (3:06 AM GMT), with the Topix index set for its highest close since 1991 over hopes that the $1.9 trillion stimulus package proposed by President Joe Biden in January will be passed by Congress.

South Korea’s KOSPI edged up 0.13%. In Australia, the ASX 200 gained 0.85% and Hong Kong’s Hang Seng Index gained 0.71%.

China’s Shanghai Composite rose 1% while the Shenzhen Component gained 0.84%.

Yellen said on Sunday that the U.S. could return to full employment in 2022 if the country enacts a robust enough relief package.

However, some investors expressed skepticism about Yellen’s statement.

“That’s a big call given full employment is 4.1%, but one that will sit well with the market at a time when the COVID-19 vaccination program is being rolled out efficiently in a number of countries,” Pepperstone chief strategist Chris Weston told Reuters.

Disappointing U.S. jobs data from Friday also continues to dent investor sentiment. The U.S. jobs report for January showed that fewer jobs were created in the economy than expected. Non-farm payrolls were at 49,000 and the unemployment rate was at 6.3%.

Further U.S. data, including the federal budget and the consumer price index, will be released later in the week.

Although the data highlighted the economic recovery’s fragility and the need for further stimulus measures, other investors warned that the introduction of these measures could boost inflation and overheat asset prices.

“It does seem to be the case that global markets have now become addicted to stimulus and that the greatest risk to the outlook, and potential trigger for a correction in risk-asset valuations, would be central banks dialing down the music,” First Abu Dhabi Bank Pjsc chief economist Simon Ballard told Bloomberg.

However, investor sentiment was boosted by a continuous global rollout of COVID-19 vaccinations. Sinovac Biotech Ltd (NASDAQ:SVA) received conditional approval from China’s National Medical Products Administration for its Coronovac offering over the weekend.

Also boosting sentiment was data suggesting that COVID-19 daily cases are declining in countries such as the U.S., France and Germany. There were also no new locally transmitted COVID-19 cases for the first time in nearly two months in China, according to data released on Monday.

Get The News You Want
Read market moving news with a personalized feed of stocks you care about.
Get The App

On the central bank front, Federal Reserve Chairman Jerome Powell will deliver remarks during a webinar on Wednesday.

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Sign out
Are you sure you want to sign out?
NoYes
CancelYes
Saving Changes